Menu

Myriad Genetics, Inc. MYGN

Full chart Compare
Set alert

Price alert · MYGN

All alert types
5.67 USD -0.07 (-1.22%)

At closeNov 10, 2026, 4:00 PM EST

5.67 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

5.55 Day range 5.75
2.74 52-week range 8.09
YTD
-7.80%
1 year
-12.50%

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $29.20MUnited States → Revenue: $768.00MExpenses → Selling, General & Admin: $537.60MExpenses → Research & Development: $106.80MExpenses → Interest Expense: $10.50MExpenses → Other Expenses: $316.80MGross Profit → Expenses: $576.60MRevenue → Gross Profit: $576.60MRevenue → Cost of Revenue: $247.90MNet Loss → Expenses: $365.90MNon-US → Revenue: $56.50MIncome Tax Benefit$29.20MGross Profit$576.60MNet Loss$365.90MCost of Revenue$247.90MExpenses$971.70MSelling, General & Admin$537.60MResearch & Development$106.80MInterest Expense$10.50MOther Expenses$316.80MRevenue$824.50MUnited States$768.00MNon-US$56.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

MYGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
824.50M837.60M753.20M678.40M690.60M
824.50M837.60M753.20M678.40M690.60M
247.90M252.20M236.20M202.00M197.60M
576.60M585.40M517.00M476.40M493.00M
963.80M708.90M774.40M617.00M683.50M
106.80M113.40M88.70M85.40M81.90M
537.60M560.00M572.90M514.70M537.80M
-387.20M-123.50M-257.40M-140.60M-190.50M
10.50M2.80M2.90M3.20M6.60M
-29.20M3.80M1.10M-28.60M-29.90M
-365.90M-127.30M-263.30M-112.00M-27.20M
-365.90M-127.30M-263.30M-112.00M-27.20M
-365.90M-127.30M-263.30M-112.00M-27.20M
-365.90M-127.30M-263.30M-112.00M-27.20M
-3.95-1.41-3.18-1.39-0.35
-3.95-1.41-3.18-1.39-0.35
-3.95-1.41-3.18-1.39-0.35
-384.60M-120.70M-259.30M-137.40M-50.50M
-384.60M-120.70M-259.30M-137.40M-50.50M
92.60M90.60M82.80M80.60M78.00M
92.60M90.60M82.80M80.60M78.00M